Self-reported adherence and reasons for nonadherence among patients with low proportion of days covered for antihypertension medications

被引:0
作者
Kharmats, Anna Y. [1 ,3 ,5 ]
Martinez, Tiffany R. [1 ]
Belli, Hayley [1 ]
Zhao, Yunan [1 ]
Mann, Devin M. [1 ,2 ,4 ]
Schoenthaler, Antoinette M. [1 ,2 ,3 ]
Voils, Corrine, I [6 ,7 ]
Blecker, Saul [1 ,2 ]
机构
[1] NYU, Med Grossman Sch Med, Dept Populat Hlth, New York, NY 10012 USA
[2] NYU, Grossman Sch Med, Dept Med, New York, NY 10012 USA
[3] NYU Langone Hlth, Inst Excellence Hlth Equ, New York, NY USA
[4] NYU Langone Hlth, Med Ctr Informat Technol, New York, NY USA
[5] Natl Inst Hlth, Off Dis Prevent, Bethesda, MD USA
[6] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA
[7] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI USA
关键词
UNITED-STATES; HYPERTENSION; DISPARITIES; VALIDATION; BARRIERS; OUTCOMES; AGENTS;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Incorporation of pharmacy fill data into the electronic health record has enabled calculations of medication adherence, as measured by proportion of days covered (PDC), to be displayed to clinicians. Although PDC values help identify patients who may be nonadherent to their medications, it does not provide information on the reasons for medication-taking behaviors.OBJECTIVE: To characterize self-reported adherence status to antihypertensive medications among patients with low refill medication adherence. Our secondary objective was to identify the most common reasons for nonadherence and examine the patient sociodemographic characteristics associated with these barriers. METHODS: Participants were adult patients seen in primary care clinics of a large, urban health system and on antihyperten-sive therapy with a PDC of less than 80% based on 6-month linked electronic health record-pharmacy fill data. We administered a validated medication adherence screener and a survey assessing reasons for antihyper-tensive medication nonadherence. We used descriptive statistics to characterize these data and logistic and Poisson regression models to assess the relationship between sociodemographic characteristics and adherence barriers.RESULTS: The survey was completed by 242 patients (57% female; 61.2% White; 79.8% not Latino/a or Hispanic). Of these patients, 45% reported missing doses of their medications in the last 7 days. In addition, 48% endorsed having at least 1 barrier to adherence and 38.4% endorsed 2 or more barriers. The most common barriers were being busy and having difficulty remembering to take medications. Compared with White participants, Black participants (incident rate ratio = 2.49; 95% CI = 1.93-3.22) and participants of other races (incident rate ratio = 2.16; 95% CI = 1.62-2.89) experienced a greater number of barriers.CONCLUSIONS: Nearly half of patients with low PDC reported nonad-herence in the prior week, suggesting PDC can be used as a screening tool. Augmenting PDC with brief self-report tools can provide insights into the reasons for nonadherence.
引用
收藏
页码:557 / 563
页数:7
相关论文
共 25 条
  • [1] Nonadherence to antihypertensive drugs A systematic review and meta-analysis
    Abegaz, Tadesse Melaku
    Shehab, Abdulla
    Gebreyohannes, Eyob Alemayehu
    Bhagavathula, Akshaya Srikanth
    Elnour, Asim Ahmed
    [J]. MEDICINE, 2017, 96 (04)
  • [2] A Systematic Review of Patient Self-Reported Barriers of Adherence to Antihypertensive Medications Using the World Health Organization Multidimensional Adherence Model
    AlGhurair, Suliman A.
    Hughes, Christine A.
    Simpson, Scot H.
    Guirguis, Lisa M.
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (12) : 877 - 886
  • [3] Blecker S, 2021, J MANAG CARE SPEC PH, V27, P1482, DOI 10.18553/jmcp.2021.27.10.1482
  • [4] Centers for Disease Control and Prevention (CDC), 2021, HYP CASC HYP PREV TR
  • [5] National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015
    Chang, Tiffany E.
    Ritchey, Matthew D.
    Park, Soyoun
    Chang, Anping
    Odom, Erika C.
    Durthaler, Jeffrey
    Jackson, Sandra L.
    Loustalot, Fleetwood
    [J]. HYPERTENSION, 2019, 74 (06) : 1324 - 1332
  • [6] Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association
    Choudhry, Niteesh K.
    Kronish, Ian M.
    Vongpatanasin, Wanpen
    Ferdinand, Keith C.
    Pavlik, Valory N.
    Egan, Brent M.
    Schoenthaler, Antoinette
    Houston Miller, Nancy
    Hyman, David J.
    [J]. HYPERTENSION, 2022, 79 (01) : E1 - E14
  • [7] Impact of Adherence to Antihypertensive Agents on Clinical Outcomes and Hospitalization Costs
    Dragomir, Alice
    Cote, Robert
    Roy, Louise
    Blais, Lucie
    Lalonde, Lyne
    Berard, Anick
    Perreault, Sylvie
    [J]. MEDICAL CARE, 2010, 48 (05) : 418 - 425
  • [8] Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis
    Durand, Hannah
    Hayes, Peter
    Morrissey, Eimear C.
    Newell, John
    Casey, Monica
    Murphy, Andrew W.
    Molloy, Gerard J.
    [J]. JOURNAL OF HYPERTENSION, 2017, 35 (12) : 2346 - 2357
  • [9] Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence
    Ferdinand, Keith C.
    Yadav, Kapil
    Nasser, Samar A.
    Clayton-Jeter, Helene D.
    Lewin, John
    Cryer, Dennis R.
    Senatore, Fortunato Fred
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2017, 19 (10) : 1015 - 1024
  • [10] Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease
    Ho, P. Michael
    Magid, David J.
    Shetterly, Susan M.
    Olson, Kari L.
    Maddox, Thomas M.
    Peterson, Pamela N.
    Masoudi, Frederick A.
    Rumsfeld, John S.
    [J]. AMERICAN HEART JOURNAL, 2008, 155 (04) : 772 - 779